Finckh, Axel

 
Title Year Hits Downloads
Prediction of Real-World Drug Effectiveness Prelaunch: Case Study in Rheumatoid Arthritis 2018 10 0
Initial validation and results of the Symptoms in Persons At Risk of Rheumatoid Arthritis (SPARRA) questionnaire: a EULAR project 2018 13 2
Low Hemoglobin and Radiographic Damage Progression in Early Rheumatoid Arthritis: Secondary Analysis From a Phase III Trial 2018 9 0
Incidence and prevalence of major adverse cardiovascular events in rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis 2018 5 0
Lessons learned from rheumatoid arthritis registries 2018 2 0
Chagas disease and systemic autoimmune diseases among Bolivian patients in Switzerland 2018 110 12
Microbiotes et rhumatismes inflammatoires 2018 6 0
Response to Tumor Necrosis Factor Inhibition in Male and Female Patients with Ankylosing Spondylitis: Data from a Swiss Cohort 2018 21 1
2017 EULAR recommendations for a core data set to support observational research and clinical care in rheumatoid arthritis 2018 14 0
Value of Biomarkers in the Prevention of Rheumatoid Arthritis 2017 56 0
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update 2017 7 0
The prevalence of anticitrullinated protein antibodies increases with age in healthy individuals at risk for rheumatoid arthritis 2017 80 3
Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registers 2017 4 0
The role of female hormonal factors in the development of rheumatoid arthritis 2017 84 0
Does addition of glucocorticoids to the initial therapy influence the later course of the disease in patients with early RA? Results from the Swiss prospective observational registry (SCQM) 2017 4 0
Differential impact of systemic lupus erythematosus and rheumatoid arthritis on health-related quality of life 2017 114 1
Body mass does not impact the clinical response to intravenous abatacept in patients with rheumatoid arthritis. Analysis from the "pan-European registry collaboration for abatacept (PANABA) 2017 3 0
Presence of IL-17 in synovial fluid identifies a potential inflammatory osteoarthritic phenotype 2017 115 46
New viral outbreaks: time for rheumatologists to get involved? 2017 65 0
Environmental factors and hormones in the development of rheumatoid arthritis 2017 57 0
Female hormonal factors and the development of anti-citrullinated protein antibodies in women at risk of rheumatoid arthritis 2017 79 5
Rheumatoid Arthritis Patients after Initiation of a New Biologic Agent: Trajectories of Disease Activity in a Large Multinational Cohort Study 2016 64 17
Impaired response to treatment with tumour necrosis factor α inhibitors in smokers with axial spondyloarthritis 2016 162 0
Points to consider for reporting, screening for and preventing selected comorbidities in chronic inflammatory rheumatic diseases in daily practice: a EULAR initiative 2016 64 0
Brief Report: Association of Rheumatoid Factor and Anti-Citrullinated Protein Antibody Positivity With Better Effectiveness of Abatacept: Results From the Pan-European Registry Analysis 2016 53 0
Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe : Preliminary Report 2016 364 10
Low pre-treatment B-cell counts are not a risk factor of infection in patients treated with rituximab for autoimmune diseases: An observational study 2016 66 0
The Effect of Comedication With a Conventional Synthetic Disease-Modifying Antirheumatic Drug on Drug Retention and Clinical Effectiveness of Anti-Tumor Necrosis Factor Therapy in Patients With Axial Spondyloarthritis 2016 74 0
Preventive Treatments for Rheumatoid Arthritis: Issues Regarding Patient Preferences 2016 113 1
Inflammatory Articular Disease in Patients with Inflammatory Bowel Disease: Result of the Swiss IBD Cohort Study 2015 138 0
Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: SWITCH-RA, a global, observational, comparative effectiveness study 2015 150 59
Effectiveness of biologic DMARDs in monotherapy versus in combination with synthetic DMARDs in rheumatoid arthritis: data from the Swiss Clinical Quality Management Registry 2015 137 0
The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial 2015 235 0
Comparative Efficacy of Novel DMARDs as Monotherapy and in Combination with Methotrexate in Rheumatoid Arthritis Patients with Inadequate Response to Conventional DMARDs: A Network Meta-Analysis 2015 158 0
An Internet-based technique for the identification of persons with symptoms of inflammatory polyarthritis of less than 12 weeks 2015 144 0
Anti-tumor necrosis factor drug survival in axial spondyloarthritis is independent of the classification criteria 2015 200 0
The EULAR Study Group for Registers and Observational Drug Studies: comparability of the patient case mix in the European biologic disease modifying anti-rheumatic drug registers 2015 200 69
The new 2010 ACR/EULAR criteria as predictor of clinical and radiographic response in patients with early arthritis 2015 153 0
Chronic NSAID use and long-term decline of renal function in a prospective rheumatoid arthritis cohort study 2015 229 0
The impact of patient heterogeneity and socioeconomic factors on abatacept retention in rheumatoid arthritis across nine European countries 2015 91 34
Facteurs de risque pour le développement d’une polyarthrite rhumatoïde 2014 206 2
The impact of obesity on the development and progression of rheumatoid arthritis 2014 193 0
Adipokines correlate with pain in lower limb osteoarthritis: different associations in hip and knee 2014 193 0
Immune-mediated experimental arthritis in IL-33 deficient mice 2014 237 1
Methotrexate in chronic-recurrent calcium pyrophosphate deposition disease: no significant effect in a randomized crossover trial 2014 262 4
Prevention of rheumatic diseases: strategies, caveats, and future directions 2014 170 0
Joint damage progression in patients with rheumatoid arthritis in clinical remission. Do biologics perform better than synthetic antirheumatic drugs? 2014 136 0
Anaemia may add information to standardised disease activity assessment to predict radiographic damage in rheumatoid arthritis: a prospective cohort study 2014 216 121
Tocilizumab in the treatment of rheumatoid arthritis: a cost-effectiveness analysis in the UK. 2014 203 285
Persistence of ultrasound synovitis in patients with rheumatoid arthritis fulfilling the DAS28 and/or the new ACR/EULAR RA remission definitions: results of an observational cohort study 2014 198 0
Smoking and spondyloarthritis 2013 190 1
The importance of early treatment for the prognosis of rheumatoid arthritis 2013 235 64
Do synovial leptin levels correlate with pain in end stage arthritis? 2013 267 2
Complications cardio-vasculaires dans les maladies auto-immunes 2013 200 1
Disease severity in K/BxN serum transfer-induced arthritis is not affected by IL-33 deficiency 2013 242 64
Primary prevention of rheumatoid arthritis: a qualitative study in a high-risk population 2013 185 1
Disease activity in rheumatoid arthritis patients at initiation of biologic agents and 1 year of treatment: results from the Swiss SCQM registry 2013 192 0
Pain as an important predictor of psychosocial health in patients with rheumatoid arthritis 2012 299 0
EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis 2012 297 418
Evaluation of cardiovascular risk in patients with rheumatoid arthritis: do cardiovascular biomarkers offer added predictive ability over established clinical risk scores? 2012 281 1
Evolution of radiographic joint damage in rituximab-treated versus TNF-treated rheumatoid arthritis cases with inadequate response to TNF antagonists 2012 183 209
Differential drug retention between anti-TNF agents and alternative biological agents after inadequate response to an anti-TNF agent in rheumatoid arthritis patients 2012 246 0
Adalimumab in acute sciatica reduces the long-term need for surgery: a 3-year follow-up of a randomised double-blind placebo-controlled trial 2012 281 0
Patient repositioning reproducibility of joint space with (JSW) measurements on hand radiographs 2011 154 0
Autoimmunity and inflammation are independent of class II transactivator type PIV-dependent class II major histocompatibility complex expression in peripheral tissues during collagen-induced arthritis 2011 238 0
Indirect comparisons of the efficacy of biological antirheumatic agents in rheumatoid arthritis in patients with an inadequate response to conventional disease-modifying antirheumatic drugs or to an anti-tumour necrosis factor agent: a meta-analysis 2011 218 1
Do new biologics meet the unmet medical need in rheumatoid arthritis? Safety and efficacy of abatacept following B-cell depletion 2011 152 1
The long-term impact of early treatment of rheumatoid arthritis on radiographic progression: a population-based cohort study 2011 232 0
Spontaneous secretion of interleukin-17 and -22 by human cervical cells in Chlamydia trachomatis infection 2011 236 0
Symptomatic effects of chondroitin 4 and chondroitin 6 sulfate on hand osteoarthritis: a randomized, double-blind, placebo-controlled clinical trial at a single center 2011 229 0
Swiss consensus statement: Recommendations for optimising re-treatment with MabThera (rituximab) in rheumatoid arthritis 2010 224 0
Anti-apolipoprotein A-1 IgG predicts major cardiovascular events in patients with rheumatoid arthritis 2010 272 2
The effect of alcohol on radiographic progression in rheumatoid arthritis 2010 231 0
Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an anti-TNF agent? 2010 210 0
Adalimumab in severe and acute sciatica: a multicenter, randomized, double-blind, placebo-controlled trial 2010 249 0
Osteoarthritis: Small studies overestimate the benefit of therapies for OA 2010 327 0
Influence of anti-infliximab antibodies and residual infliximab concentrations on the occurrence of acquired drug resistance to infliximab in rheumatoid arthritis patients 2010 235 0
Comparative effectiveness of rheumatoid arthritis therapies 2010 153 0
EULAR points to consider when establishing, analysing and reporting safety data of biologics registers in rheumatology 2010 210 0
A comparison of patient characteristics and outcomes in selected European and U.S. rheumatoid arthritis registries 2010 233 0
Diagnostic value of anti-cyclic citrullinated peptides and association with HLA-DRB1 shared epitope alleles in African rheumatoid arthritis patients 2010 266 317
Cost-effectiveness of biologics in early rheumatoid arthritis 2010 222 0
BMI and severity of clinical and radiographic signs of hip osteoarthritis 2009 230 0
The effectiveness of leflunomide as a co-therapy of tumour necrosis factor inhibitors in rheumatoid arthritis: a population-based study 2009 186 7
Comparison of drug retention rates and causes of drug discontinuation between anti-tumor necrosis factor agents in rheumatoid arthritis 2009 228 0
Influence of cytokine inhibitors on concentration and activity of MMP-1 and MMP-3 in disc herniation 2009 243 70
Clinical experience with mycophenolate mofetil in systemic autoimmune conditions refractory to common immunosuppressive therapies 2009 261 156
Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis 2009 240 1
At the horizon of innovative therapy in rheumatology: new biologic agents 2008 222 9
Primer: strengths and weaknesses of meta-analysis 2008 227 1
Neutral functional realignment orthosis prevents hand pain in patients with subacute stroke: a randomized trial 2008 179 1
Elevated levels of tumor necrosis factor-alpha in periradicular fat tissue in patients with radiculopathy from herniated disc 2008 245 0
Fibromyalgia: a randomised, controlled trial of a treatment programme based on self management 2004 89 1
Neurophysiologic evidence for a central sensitization in patients with fibromyalgia 2003 102 130
15508 2131